In vitro and in vivo activities of QA-241, a new tricyclic quinolone derivative.

The in vitro susceptibilities of 1,310 clinical isolates to QA-241, a novel tricyclic quinolone, were evaluated in comparison with susceptibilities to norfloxacin, ofloxacin, enoxacin, and ciprofloxacin. The MICs of QA-241 for 90% of staphylococci, Enterococcus faecalis isolates, and streptococcal s...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Asahara, M, Tsuji, A, Goto, S, Masuda, K, Kiuchi, A
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1989
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172615/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2679369/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.8.1144
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!